Mark Sullivan - Net Worth and Insider Trading

Mark Sullivan Net Worth

The estimated net worth of Mark Sullivan is at least $12 Million dollars as of 2026-09-11. Mark Sullivan is the Chief Legal Officer of Definium Therapeutics Inc and owns about 320,571 shares of Definium Therapeutics Inc (DFTX) stock worth over $12 Million. Mark Sullivan is also the General Counsel & Secretary of Sesen Bio Inc and owns about 18,933 shares of Sesen Bio Inc (SESN) stock worth over $11,905. Details can be seen in Mark Sullivan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Sullivan has not made any transactions after 2026-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mark Sullivan

To

Mark Sullivan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Sullivan owns 3 companies in total, including Sesen Bio Inc (SESN) , CARISMA Therapeutics Inc (CARM) , and Definium Therapeutics Inc (DFTX) .

Click here to see the complete history of Mark Sullivan’s form 4 insider trades.

Insider Ownership Summary of Mark Sullivan

Ticker Company Transaction Date Type of Owner
SESN Sesen Bio Inc 2023-03-02 General Counsel & Secretary
CARM CARISMA Therapeutics Inc 2019-08-01 General Counsel & Secretary
DFTX Definium Therapeutics Inc 2026-06-25 Chief Legal Officer

Mark Sullivan Latest Holdings Summary

Mark Sullivan currently owns a total of 2 stocks. Among these stocks, Mark Sullivan owns 320,571 shares of Definium Therapeutics Inc (DFTX) as of June 25, 2026, with a value of $12 Million and a weighting of 99.9%. Mark Sullivan also owns 18,933 shares of Sesen Bio Inc (SESN) as of March 2, 2023, with a value of $11,905 and a weighting of 0.1%.

Latest Holdings of Mark Sullivan

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DFTX Definium Therapeutics Inc 2026-06-25 320,571 38.89 12,467,006
SESN Sesen Bio Inc 2023-03-02 18,933 0.63 11,905

Holding Weightings of Mark Sullivan


Mark Sullivan Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Sullivan has made a total of 8 transactions in Definium Therapeutics Inc (DFTX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Definium Therapeutics Inc is the sale of 13,008 shares on June 25, 2026, which brought Mark Sullivan around $585,750.

According to the SEC Form 4 filings, Mark Sullivan has made a total of 2 transactions in Sesen Bio Inc (SESN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sesen Bio Inc is the sale of 10,961 shares on March 2, 2023, which brought Mark Sullivan around $129,339.

Insider Trading History of Mark Sullivan

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Sullivan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Mark Sullivan owns.
View DFTX Analysis

Mark Sullivan Ownership Network

Ownership Network List of Mark Sullivan

No Data

Ownership Network Relation of Mark Sullivan

Insider Network Chart


Mark Sullivan Owned Company Details

What does Sesen Bio Inc do?

Who are the key executives at Sesen Bio Inc?

Mark Sullivan is the General Counsel & Secretary of Sesen Bio Inc. Other key executives at Sesen Bio Inc include 10 percent owner Modernatx, Inc. , Chief Scientific Officer Michael Klichinsky , and director & President and CEO Steven Kelly .

Sesen Bio Inc (SESN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sesen Bio Inc (SESN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sesen Bio Inc (SESN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sesen Bio Inc (SESN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sesen Bio Inc Insider Transactions

No Available Data

Mark Sullivan Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Sullivan. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark Sullivan's mailing address is: Mount Laurel Nj 08054.